{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:42Z","timestamp":1761540342230},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":295,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>The diagnosis of biliary disease, namely malignant disorders, is frequently hampered by the inconclusive cytology. We investigated prospectively the frequency of molecular changes in p53 and ras compared with cytology in patients with primary or secondary hepato\u2010biliary disease.<\/jats:p><jats:p>We investigated 118 consecutive patients, aged 24\u201389 with the following clincal diagnoses: choledocho\/cholecystolithiasis (28), cholangiocellular carcinoma (21), gall bladder tumor (8), liver metastasis (3), autoimmune disease (8), chronic pancreatitis (16), pancreatic carcinoma (11), papillary disease (4), hepatic cirrhosis (6), cholangitis (2), anomalies (2), and normal (9). Bile was aspirated during routine endoscopic retrograde cholangio pancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC). DNA was prepared freshly from a native aliquot. p53 mutations were detected by polymerase chain reaction (PCR) for exons 5 through 8 followed by TGGE. PCR for ras mutations was performed as RFLP\u2013PCR with sequencing.<\/jats:p><jats:p>In four cases, mutations in p53 could be found in exons 6 and 7. Twenty\u2010two samples showed ras mutations; ras mutations were found in choledocholithiasis (4\/28), bile duct (5\/21), gall bladder (3\/8) and pancreatic (1\/11) carcinoma, liver metastasis (3\/3), ulcerative colitis (2\/3), PSC (1\/2), and chronic pancreatitis (1\/16). Cytology was clearly positive in seven cases, suspicious in three other, inconclusive in six, and negative in the rest. The molecular analysis resulted in a sensitivity of 33% and specificity of 87%, respectively, for the diagnosis of a malignant condition.<\/jats:p><jats:p>PCR for p53 and ras mutations may aid the diagnosis of primary and secondary (metastatic) hepatobiliary disease if a malignant condition of the bile ducts and the liver is suspected and cytology is inconclusive or negative. However, the incidence of p53 and ras mutations in bile seems less frequent than in other malignant conditions of the gastrointestinal tract and the pancreas and lower than in tissue, leaving a poor sensitiviy and specificity. Nevertheless, the presence of a p53 and\/or ras mutation <jats:italic>per se<\/jats:italic> supports a clinical suspicion of malignancy, even when the conventional cytology is negative or inconclusive.<\/jats:p>","DOI":"10.1046\/j.1365-2362.2001.00800.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:51:19Z","timestamp":1047397879000},"page":"240-247","source":"Crossref","is-referenced-by-count":19,"title":["Low frequency of p53 and ras mutations in bile of patients with hepato\u2010biliary disease: a prospective study in more than 100 patients"],"prefix":"10.1111","volume":"31","author":[{"given":"P.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ostwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"P\u00fcschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Plath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Barten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nizze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. D.","family":"Schareck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hauenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Liebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"L\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(94)70154-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19991025)87:5<306::aid-cncr11>3.0.co;2-y"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(94)70155-5"},{"key":"e_1_2_6_5_2","volume-title":"Biliary and pancreatic ductal epithelia. Pathobiology and Pathophysiology.","author":"Sirica AE","year":"1997"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70244-0"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90710-0"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90606-L"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910570206"},{"key":"e_1_2_6_10_2","first-page":"289","article-title":"p53 and k\u2010ras alterations in pancreatic epithelial cell lesions","volume":"8","author":"Kalthoff H","year":"1993","journal-title":"Oncogene"},{"key":"e_1_2_6_11_2","first-page":"1503","article-title":"Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb\u20101 tumor suppressor genes","volume":"7","author":"Ruggeri B","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","unstructured":"L\u00f6hrM M\u00fcllerP MoraJ BrinkmannB OstwaldC PlathFet al.p53 and ras mutations in pancreatic juice samples of patients with chronic pancreatitis.Gastrointest Endoscopy 2001;53:in press.","DOI":"10.1067\/mge.2001.112711"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1055414"},{"key":"e_1_2_6_14_2","first-page":"1147","article-title":"Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K\u2010ras mutation","volume":"5","author":"Yamaguchi Y","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3220809"},{"key":"e_1_2_6_16_2","first-page":"2472","article-title":"Detection of ras gene mutation in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma","volume":"53","author":"Tada M","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02786120","article-title":"Detection of c\u2010ki\u2010ras point mutation from pancreatic juice","volume":"14","author":"Miki H","year":"1993","journal-title":"Int J Pancreatol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220313"},{"key":"e_1_2_6_19_2","first-page":"629","article-title":"Clinical value of K\u2010ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis","volume":"5","author":"Sturm PD","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1996.tb00712.x"},{"key":"e_1_2_6_21_2","first-page":"1211","article-title":"Point mutations of the c\u2010Ki\u2010ras gene in carcinoma and atypical epithelium associated with congenital biliary dilatation","volume":"91","author":"Tomono H","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90650-9"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-27"},{"key":"e_1_2_6_24_2","first-page":"2756","article-title":"Mutations of p16Ink4\/CDKN2 and p15Ink4B\/MTS2 genes in biliary tract cancers","volume":"55","author":"Yoshida S","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00196520"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:25:1:39"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.9.3606"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/15.10.2221"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199602000-00002"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.12.2155"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8536861"},{"key":"e_1_2_6_32_2","first-page":"1019","article-title":"Usefulness of k\u2010ras gene mutation at codon 12 in bile for diagnosing biliary strictures","volume":"12","author":"Ito R","year":"1998","journal-title":"Int J Oncol"},{"key":"e_1_2_6_33_2","first-page":"795","article-title":"Detection of mutated c\u2010ki\u2010ras in the bile of patients with pancreatic cancer","volume":"17","author":"Abbruzzese JL","year":"1997","journal-title":"Anticancer Res"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.357"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.7.1679"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940080415"},{"key":"e_1_2_6_37_2","first-page":"305","article-title":"High rates of ki\u2010ras point mutations in both intra\u2010 and extra\u2010hepatic cholangiocarcinomas","volume":"24","author":"Ohashi K","year":"1994","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940601)73:11<2727::AID-CNCR2820731113>3.0.CO;2-#"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00821.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199807)68:3<187::AID-JSO11>3.0.CO;2-Z"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.3.426"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980715)83:2<267::aid-cncr10>3.0.co;2-r"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02784944"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19960415)77:8<1752::aid-cncr51>3.0.co;2-v"},{"key":"e_1_2_6_45_2","first-page":"1","article-title":"K\u2010ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers \u2013 a review","volume":"24","author":"Minamoto T","year":"2000","journal-title":"Cancer Detect Prev"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:27:2:093"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940901)74:5<1542::AID-CNCR2820740508>3.0.CO;2-U"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004230050107"},{"key":"e_1_2_6_49_2","first-page":"4740","article-title":"Inactivation of the p16 (INK4A) tumor\u2010suppressor gene in pancreatic duct lesions: loss of intranuclear expression","volume":"58","author":"Wilentz RE","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19990415)85:8<1703::aid-cncr9>3.0.co;2-r"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(98)70248-2"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018803532543"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305203282001"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1998.tb03825.x"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00800.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00800.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.2001.00800.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T09:23:16Z","timestamp":1695720196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.2001.00800.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2362.2001.00800.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.2001.00800.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}